Androgen deprivation and radiation therapy: Sequencing studies using the shionogi in vivo tumor system

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 5, 1997, Pages 1067-1070

  Zietman, Anthony L ^a   Prince, Ethan A ^a   Nakfoor, Bruce M ^a   Park, Jeannine J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Androgen deprivation; Radiation; Shionogi tumor

Indexed keywords

ALLOGRAFT; ANDROGEN RELEASE; ANIMAL CELL; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; GROWTH INHIBITION; IN VIVO STUDY; MOUSE; NONHUMAN; ORCHIECTOMY; PRIORITY JOURNAL; RADIATION RESPONSE; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ANDROGENS; ANIMALS; COMBINED MODALITY THERAPY; MALE; MICE; MICE, NUDE; NEOPLASMS, HORMONE-DEPENDENT; ORCHIECTOMY; TUMOR CELLS, CULTURED;

EID: 0030811994     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00309-X     Document Type: Article

References (14)

1. Bagshaw, M. J.; Cox, R. S.; Hancock, S. L. Control of prostate cancer with radiotherapy: Long-term results. J. Urol. 152:1781-1785; 1994.
2. Bruchovsky, N.; Rennie, P. S.; Coldman, A. J.; Goldenberg, S. L.; To, M.; Dawson, D. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res. 50:2275-2282; 1990.
3. Daneshgari, F.; Crawford, E. D. Endocrine therapy of advanced cancer of the prostate. Cancer 71:1089-1097; 1993.
4. Fuks, Z.; Haimowitz-Friedman, A.; Kolesnick, R. N. The role of the sphingomyelin pathway and protein kinase C in radiation-induced cell kill. In: DeVita, V. T.; Hellman, S.; Rosenberg, S. A., eds. Important advances in oncology. Philadelphia, PA: J. B. Lippincott; 1995:19-31.
5. Gleave, M.; Goldenberg, S. L.; Jones, E. C.; Bruchovsky, N.; Sullivan, L. D. Biochemical and pathologic effects of 8 months of of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. J. Urol. 155:213-219; 1996.
6. Laverdiere, J.; Gomez, J. L.; Cusan, L.; Suburu, E. R.; Diamond, P.; Lemay, M.; Candas, B.; Labrie, F. Beneficial effect of combination therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int. J. Radiat. Oncol. Phys. 37:247-252; 1997.
7. Lim Joon, D.; Hasegawa, M.; Wu, C. S.; Sikes, C.; Khoo, V. S.; Zagars, G. K.; Terry, N. H. A.; Meistrich, M. L.; Pollack, A. Supra-additive apoptotic response in predominantly quiescent prostate tumors when treated with androgen-ablation and radiotherapy. Int. J. Radiat. Biol. Phys. 36:191; 1996.
8. Meyn, R. E.; Stephens, L. C.; Ang, K. K.; Hunter, N. R.; Brock, W. A.; Milas, L.; Peters, L. J. Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int. J. Radiat. Biol. 64:583-591; 1993.
9. Minesita, T.; Yamaguchi, T. An androgen-dependent mouse mammary tumor. Cancer Res. 25:1168-1175; 1965.
10. Pilepich, M. V.; Krall, J. M.; Al-Sarraf, M.; Scotte-Doggett, R. L.; Sause, W. T.; Lawton, C. A.; Abrams, R. A.; Rotman, M.; Rubin, P.; Shipley, W. U.; Grignon, D.; Caplan, R.; Cox, J. D. Androgen deprivation with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45:616-623; 1995.
11. Sneller, Z.; Hop, W. C.; Carpentier, P.; Schroeder, F. H. Prognosis and prostate volume changes during endocrine management of prostate carcinoma: A longitudinal study. J. Urol. 147:962; 1992.
12. Suit, H. D.; Shalek, R. J.; Wette, R. Radiation response of C3H mouse mammary carcinoma evaluated in terms of cellular radiosensitivity. In: Shalek, R. J.; et al., eds., Cellular radiation biology. Baltimore: Williams and Wilkins Co.; 1965:514-530.
13. Zietman, A. L.; Coen, J. J.; Dallow, K. A.; Shipley, W. U. The treatment of prostate cancer by conventional radiation therapy: An analysis of long term outcome. Int. J. Radiat. Oncol. Biol. Phys. 32:287-292; 1995.
14. Zietmanm, A. L.; Nakfoor, B. M.; Prince, E. A.; Gerweck, L. E.; Shipley, W. U. The effect of androgen deprivation on an androgen sensitive tumor: An in vitro and in vivo study. Cancer J. Sci. Am. 3:31-36; 1997.